The 65th session of the Commission on Narcotic Drugs (CND) is expected to take place on 14-18 March 2022.

IDPC offers a historical analysis of civil society advocacy for drug policy reform at the UN, assessing gains, challenges and insight on how the latter have been generally overcome.

IDPC takes stock of progress made on the implementation of the recommendations included in the UNGASS Outcome Document, focusing on six critical areas: public health, development, human rights, civil society engagement, UN agency collaboration and cooperation, and drug policy evaluation.

IDPC and TNI provide an overview of the evolution of the UN-agreed language on key drug policy issues for the last three decades.

Civil society experts concerned the new Agenda and Action plan turns its back to the EU's 'balanced approach' on drug policy.

UNODC compiles data on thriving drug markets, noting a 30% rise in use over the last decade yet remaining mostly silent on human rights impact of drug control.

IDPC offers recommendations to the new UNODC Director related to a range of key concerns, including on UN system-wide coherence, human rights and health.

The INCB highlights the fundamental role of civil society engagement in the development and implementation of drug policies.